How would you answer this 3 F/S question?

You're company A and you raise capital through bonds to buy PP&E, after two years it is determined your value of the purchased equipment is actually lower by $2MM. You sell the equipment 5 years later. Tell me what happens to statements in each of the three stages.

My noob take on it:

raising capital through bonds:
IS- nothing ( in year 0, but then interest expense afterwards)
CF- increase in Financing activities
bs- cap ex increases, liabilities increase

buying the pp&e
IS- nothing
CF- decrease in financing activiities
bs- cap ex decrease, pp&e increase, Liabilities stay the same

value lowered by 2mm
Lost on this

Sell equipment
Lost

I understand there will be interest expenses and depreciation each year, but I left those out to simplify the concept

10 Comments
 
Loki777

Hey, I had previously seen that, but I am not sure how the reduction in value and the equipment being sold affects the f/s

You would impair the PPE by the two million which would decrease your carrying value of the equipment and show up on the IS.

As for the sale, you would need the carrying value of the PPE (historical price-depreciation) and see if there is any difference between that and the selling price. If there is then you would have a recognized gain or loss. As for the BS impact, you would show a decrease in PPE and increase in cash.

The other impact you should think about is the BS impact of the depreciation expense.

 
Best Response

bl00211 identified the right gaps in your analysis.

I'd rewrite it as:

Raising capital through bonds: IS- interest expense CF- inflow in Financing on raising the bonds, outflow from Operations for interest, outflow from Financing on repayment (plus potentially inflow for any refinance) BS - cash at bank increases (not capex - capex is not a b/s item); borrowings increase (split between current and non-current depends on tenor of the bonds and whether it's bullet or amortising)

Buying the pp&e IS - nothing in Year 0, depreciation afterwards CF- outflow in Investing activities (not financing) on acquisition BS - increase in PP&E (again, capex is not a BS item, so no decrease), decrease in cash at bank, no change in liabilities, accumulated depreciation will accrue over life of the PP&E

Value lowered by 2mm IS - $2m impairment on recognition BS - reduction in PP&E on the $2m impairment CF - no impact

Sell equipment IS - Any difference between sale value and book value (PP&E balance net of accumulated depreciation) is booked as gain/loss on sale BS - reduction in PP&E, increase in cash at bank CF - increase in Investing activities

Those who can, do. Those who can't, post threads about how to do it on WSO.
 
SSits

bl00211 identified the right gaps in your analysis.

I'd rewrite it as:

Raising capital through bonds:
IS- interest expense
CF- inflow in Financing on raising the bonds, outflow from Operations for interest, outflow from Financing on repayment (plus potentially inflow for any refinance)
BS - cash at bank increases (not capex - capex is not a b/s item); borrowings increase (split between current and non-current depends on tenor of the bonds and whether it's bullet or amortising)

Buying the pp&e
IS - nothing in Year 0, depreciation afterwards
CF- outflow in Investing activities (not financing) on acquisition
BS - increase in PP&E (again, capex is not a BS item, so no decrease), decrease in cash at bank, no change in liabilities, accumulated depreciation will accrue over life of the PP&E

Value lowered by 2mm
IS - $2m impairment on recognition
BS - reduction in PP&E on the $2m impairment
CF - no impact

Sell equipment
IS - Any difference between sale value and book value (PP&E balance net of accumulated depreciation) is booked as gain/loss on sale
BS - reduction in PP&E, increase in cash at bank
CF - increase in Investing activities

awesome summary. one thing i would add tho is that when you take the impairment charge on the PP&E, the CF is impacted via lower Net Income which comes through Cash Flows from Operating Activities

 

Depends on the tax rules of the jurisdiction you're in.

I expect it would be no tax on the cash raised from the bond issue, as that's capital in nature for tax purposes.

As interest accrues on the bonds, you'd get a tax deduction for the interest.

If there is any original issuer discount (OID) on the bond (eg it's issued at $97 on a $100 par value, representing a 3% OID), then it depends on local tax rules. At a guess, I'd say the OID is treated as part of the interest expense and the OID is amortised over the life of the bond for tax deduction purposes.

Those who can, do. Those who can't, post threads about how to do it on WSO.
 

Raise $ via bonds & purchase PP&E IS: Interest expense from BP Increased depreciation expense from new PP&E

Balance sheet Increase in bonds payable Increase in fixed assets Increase in accumulated depreciation

Statement of cash flows: Operating cash flow: +Depreciation expense -Interest on BP

Investing cash flows: - Purchase of PP&E

Investing cash flows: + Proceeds from bonds issued

2 years later: IS: Impairment loss -2M

BS: Fixed assets decline by 2M

Cash flows: Operating: impairment is a non-cash charge --> add back impairment loss to net income arrive at operating cash flow

Note you still have interest expense and depreciation as in year 1.

Year 5 (year of sale) Balance sheet -Remove PP&E -Remove accumulated depreciation + Cash

IS: Either gain or loss on asset sale depending on what book value of asset is

Cash flows: Operating: Add back/subtract loss/gain on asset sale as this is non-cash item. Investing: Cash inflow from asset sale

i hate audit SSits:

bl00211 identified the right gaps in your analysis.

I'd rewrite it as:

Raising capital through bonds:
IS- interest expense
CF- inflow in Financing on raising the bonds, outflow from Operations for interest, outflow from Financing on repayment (plus potentially inflow for any refinance)
BS - cash at bank increases (not capex - capex is not a b/s item); borrowings increase (split between current and non-current depends on tenor of the bonds and whether it's bullet or amortising)

Buying the pp&e
IS - nothing in Year 0, depreciation afterwards
CF- outflow in Investing activities (not financing) on acquisition
BS - increase in PP&E (again, capex is not a BS item, so no decrease), decrease in cash at bank, no change in liabilities, accumulated depreciation will accrue over life of the PP&E

Value lowered by 2mm
IS - $2m impairment on recognition
BS - reduction in PP&E on the $2m impairment
CF - no impact

Sell equipment
IS - Any difference between sale value and book value (PP&E balance net of accumulated depreciation) is booked as gain/loss on sale
BS - reduction in PP&E, increase in cash at bank
CF - increase in Investing activities

awesome summary. one thing i would add tho is that when you take the impairment charge on the PP&E, the CF is impacted via lower Net Income which comes through Cash Flows from Operating Activities

I agree what you said about statement of cashflow being impacted through lower net income due to impairment loss; only thing to add is that yes NI will decline but you are adding back the non-cash loss/expense to NI. Impairment loss will also be a tax shield on the income statement.

 

Sed iure iure voluptatem ipsum. Sint possimus accusamus blanditiis quis iste aliquam impedit. Neque eos reprehenderit est saepe et odit officia.

Et et adipisci quidem sit voluptates laborum. Assumenda qui repellendus perferendis delectus qui maxime quae. Temporibus dolorem corrupti molestiae voluptatem illum. Ut quia itaque ut officiis est nihil. Tempora aliquid magnam aperiam corporis omnis.

Sint inventore officia maxime aliquam possimus. Illo maxime qui id provident repellat. Voluptatem praesentium pariatur vel ex tempore eligendi. Aspernatur qui est vero molestias labore qui.

Career Advancement Opportunities

May 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

May 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

May 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

May 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (65) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
CompBanker's picture
CompBanker
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”